Baker Brothers Advisors - KARUNA THERAPEUTICS INC ownership

KARUNA THERAPEUTICS INC's ticker is KRTX and the CUSIP is 48576A100. A total of 161 filers reported holding KARUNA THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 0.69 and the average weighting 0.5%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of KARUNA THERAPEUTICS INC
ValueSharesWeighting
Q2 2022$8,851,000
-0.2%
69,9660.0%0.05%
-2.0%
Q1 2022$8,871,000
-3.2%
69,9660.0%0.05%
+13.3%
Q4 2021$9,166,000
+7.1%
69,9660.0%0.04%
+18.4%
Q3 2021$8,559,000
+7.3%
69,9660.0%0.04%
+8.6%
Q2 2021$7,975,000
-5.2%
69,9660.0%0.04%
-2.8%
Q1 2021$8,412,000
+18.3%
69,9660.0%0.04%
+33.3%
Q4 2020$7,108,000
+18.2%
69,966
-10.0%
0.03%
+12.5%
Q3 2020$6,014,000
-34.2%
77,776
-5.1%
0.02%
-40.0%
Q2 2020$9,137,000
+202.3%
81,976
+95.3%
0.04%
+110.5%
Q1 2020$3,022,00041,9760.02%
Other shareholders
KARUNA THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Pivotal bioVenture Partners Investment Advisor LLC 782,008$142,043,93358.49%
Nan Fung Group Holdings Ltd 225,688$40,993,96827.90%
Sofinnova Investments, Inc. 1,773,124$322,070,24320.60%
Artia Global Partners LP 88,831$16,135,2635.96%
DAFNA Capital Management LLC 78,573$14,272,0004.28%
First Light Asset Management, LLC 243,675$44,261,1273.98%
CATALYST PRIVATE WEALTH, LLC 21,837$3,966,4732.74%
Sands Capital Ventures, LLC 58,895$10,697,6882.64%
ARCH Venture Management, LLC 30,000$5,449,2002.63%
Logos Global Management LP 100,000$18,164,0002.60%
View complete list of KARUNA THERAPEUTICS INC shareholders